Belbuca: Medgend

Belbuca FDA Approved Drugs

BELBUCA [Buprenorphine Hydrochloride^{C₂₉H₄₁NO₄ClH}]

eq 0.075mg base (buccal film)

eq 0.15mg base (buccal film)

eq 0.3mg base (buccal film)

eq 0.45mg base (buccal film)

eq 0.6mg base (buccal film)

eq 0.75mg base (buccal film)

eq 0.9mg base (buccal film)

Bdsi^{Oct 23, 2015}

Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate..
Treatement of pain by transmucosal delivery of buprenorphine.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

BUPRENEX [Buprenorphine Hydrochloride^{C₂₉H₄₁NO₄ClH}]

eq 0.3mg base/ml (injection injectable)

Indivior Inc^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

BUPRENORPHINE HYDROCHLORIDE [Buprenorphine Hydrochloride^{C₂₉H₄₁NO₄ClH}]

eq 0.3mg base/ml (injection injectable)

eq 2mg base (sublingual tablet)

eq 8mg base (sublingual tablet)

Hospira^{Jun 3, 1996}
Luitpold^{Mar 27, 2007}
Par Sterile Products^{Jul 28, 2015}
West-ward Pharms Int^{Mar 2, 2005}
Actavis Elizabeth^{Feb 19, 2015}
Barr^{May 7, 2010}
Ethypharm^{Sep 24, 2010}
Mylan Pharms Inc^{Mar 6, 2015}
Rhodes Pharms^{Mar 27, 2017}
Sandoz Inc^{Jun 10, 2015}
Sun Pharm Inds Ltd^{Jan 29, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

PROBUPHINE [Buprenorphine Hydrochloride^{C₂₉H₄₁NO₄ClH}]

eq 80mg base/implant (implantation implant)

Braeburn Pharms Inc^{May 26, 2016}

For opioid dependence.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.